Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs. | Mol Ther;30(10): 3333, 2022 Oct 05. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs.

Crippa, Stefania; Conti, Anastasia; Vavassori, Valentina; Ferrari, Samuele; Beretta, Stefano; Rivis, Silvia; Bosotti, Roberto; Scala, Serena; Pirroni, Stefania; Jofra-Hernandez, Raisa; Santi, Ludovica; Basso-Ricci, Luca; Merelli, Ivan; Genovese, Pietro; Aiuti, Alessandro; Naldini, Luigi; Di Micco, Raffaella; Bernardo, Maria Ester.

Mol Ther ; 30(10): 3333, 2022 Oct 05.

Article in En | MEDLINE | ID: mdl-36096132

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Mol Ther Journal subject: BIOLOGIA MOLECULAR / TERAPEUTICA Year: 2022 Document type: Article Country of publication: United States

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Mol Ther Journal subject: BIOLOGIA MOLECULAR / TERAPEUTICA Year: 2022 Document type: Article Country of publication: United States